The National Institutes of Health (NIH) is offering a Limited Competition Notice of Funding Opportunity (NOFO) for the Outcomes of Electronic Medical Records and Genomics (eMERGE) Genomic Risk Assessment and Management Network – Clinical Sites. This initiative invites organizations previously funded under RFA-HG-19-013 and RFA-HG-19-014 to participate in a clinical trial aimed at assessing the long-term adherence to and outcomes of genomically informed risk assessments (GIRA) for approximately 25,000 patients. The program is crucial for understanding the effectiveness of GIRA-based preventative recommendations and identifying factors influencing patient adherence. Interested applicants must submit their proposals by January 30, 2026, with an estimated total program funding of $5.8 million allocated for ten awards over the fiscal years 2026 to 2029. For further inquiries, applicants can contact the Division of Genomic Medicine at NHGRI_DGMed@nih.gov.